Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Vanguard Short Term Corporate Bond ETF — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Vanguard Short Term Corporate Bond ETF trades at $77.34 (market cap $51.90B). The key difference: Vanguard Short Term Corporate Bond ETF is far larger — about 30.4× Nuvation Bio Inc. Class A Common Stock's market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, Vanguard Short Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Vanguard Short Term Corporate Bond ETF for 52 Days on average.
| NUVB | VCSH | |
|---|---|---|
Market Cap | $1.71B | $51.90B |
Volume | 5,448,712 | 5,450,864 |
Sector | Health | Fixed Income |
52-Week High | $9.54 | $80.20 |
52-Week Low | $3.41 | $77.03 |
Typical Hold Time | 0 Days | 52 Days |
Enterprise Value | $1.30B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VCSH trades at $77.27 with minimal daily movement (+0.08%). Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators remain neutral. The ETF maintains a competitive 4.5% dividend yield with a short 2.7-year duration, providing stability amid rate uncertainty. Recent news highlights institutional positioning shifts and comparisons with peer funds.
VCSH offers conservative investors exposure to high-quality short-term corporate bonds with minimal interest rate risk. The primary opportunity lies in its higher yield compared to Treasury alternatives, though credit spreads remain tight. Key risks include potential credit deterioration and limited price appreciation given current market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
